52-Week High Companies: HDFC Bank Ltd., Enersis S.A. Kubota Corp., Quest Diagnostics Inc., Banco Santander Chile, and Vertex Pharmaceuticals Inc.

52-Week High Companies

Author's Avatar
Jun 27, 2009
According to GuruFocus updates, these Guru stocks have reached their 52-Week Highs: HDFC Bank Ltd. (HDB, Financial), Enersis S.A. (ENI, Financial), Kubota Corp. (KUB, Financial), Quest Diagnostics Inc. (DGX, Financial), Banco Santander Chile (SAN, Financial), and Vertex Pharmaceuticals Inc. (VRTX, Financial)

HDFC Bank Ltd. (HDB) Reached the 52-Week High of $105.93

HDFC Bank Ltd.'s aim is to build a sound customer franchise across distinct businesses so as to be the preferred provider of banking services in the niche segments that the bank operates in and to achieve healthy growth in profitability consistent with the bank's risk appetite. HDFC Bank Ltd. has a market cap of $12.51 billion; its shares were traded at around $105.93 with a P/E ratio of 30.7 and P/S ratio of 3. HDFC Bank Ltd. had an annual average earning growth of 60.7% over the past 5 years.

For the quarter ended March 31, 2009, the Bank earned total income of Rs.5,365.5 crores as against Rs.3,505.5 crores in the corresponding quarter ended March 31, 2008, registering a growth of 53.1%. Net revenues were Rs.2,966.7 crores for the quarter ended March 31, 2009, an increase of 35.4% over Rs.2,191.4 crores for the corresponding quarter of the previous year.

HDB is in the portfolio of Kenneth Fisher of Fisher Asset Management, LLC.

Enersis S.A. (ENI) Reached the 52-Week High of $18.21

Enersis S.A. generates and distributes electricity in Chile, Argentina, and Peru. The company also develops real estate projects and provides engineering and other services that are principally an extension of its utility operations. Enersis S.A. has a market cap of $11.89 billion; its shares were traded at around $18.21 with a P/E ratio of 30.2 and P/S ratio of 1.1. The dividend yield of Enersis S.A. stocks is 2.9%. Enersis S.A. had an annual average earning growth of 30.2% over the past 5 years.

Enersis S.A. recently posted a net profit of 152.05 billion pesos ($260.32 million) for the first quarter, up from the CLP101.03 billion it posted for the period in 2008.

Kubota Corp. (KUB) Reached the 52-Week High of $42.8

Kubota is the world's largest maker of small tractors and Japan's second largest manufacturer of farm equipment. The company is also Japan's largest producer of ductile iron pipe (for water supply and sewer systems) and maker of roofing materials. Kubota Corp. has a market cap of $10.89 billion; its shares were traded at around $42.8 with a P/E ratio of 0.5 and P/S ratio of 0.9. The dividend yield of Kubota Corp. stocks is 1.5%. Kubota Corp. had an annual average earning growth of 18.1% over the past 10 years.

As of April 2, 2009, Kubota Corp. had an operating income of $1,038.3 million.

Quest Diagnostics Inc. (DGX) Reached the 52-Week High of $55.25

Quest Diagnostics Inc. is the leading provider of diagnostic testing information and services that patients and doctors need to make better healthcare decisions. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Quest Diagnostics Inc. has a market cap of $10.24 billion; its shares were traded at around $55.25 with a P/E ratio of 16 and P/S ratio of 1.3. The dividend yield of Quest Diagnostics Inc. stocks is 0.8%. Quest Diagnostics Inc. had an annual average earning growth of 23.9% over the past 10 years. GuruFocus rated Quest Diagnostics Inc. the business predictability rank of 4-star.

On April 21, 2009, Quest Diagnostics Inc. announced that for the first quarter ended March 31, 2009, income from continuing operations was $169 million compared to $141 million in the first quarter of 2008. First quarter revenues increased 1.3% to $1.8 billion.Â

DGX is in the portfolios of Edward Owens of Vanguard Health Care Fund, Robert Olstein of Olstein Financial Alert Fund, and John Hussman of Hussman Economtrics Advisors, Inc.

In February, Sell: Chairman, President & CEO, Director Surya N Mohapatra sold 10,884 shares of DGX stock; the price of the stock has increased by 11.06% since. Many other owners and directors sold shares in March and February as well.

Banco Santander Chile (SAN) Reached the 52-Week High of $45.8

Banco Santiago is the largest bank in Chile in terms of assets with Ch$4088 billion (approximately US$9.86 billion ) as of March 31 1997. Banco Santander Chile has a market cap of $8.31 billion; its shares were traded at around $45.8 with a P/E ratio of 13.6 and P/S ratio of 2. The dividend yield of Banco SantanderChile stocks is 2.9%. Banco SantanderChile had an annual average earning growth of 64% over the past 5 years.

For the quarter ended December 31, 2009, Banco Santiago had a revenue of $475.5 million compared to $312.5 million a year ago. Net income was $121.1 million compared to $166.5 million.

Vertex Pharmaceuticals Inc. (VRTX) Reached the 52-Week High of $36.04

Vertex Pharmaceuticals Inc. discovers, develops, and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune, diseases and neurological disorders. Vertex Pharmaceuticals Inc. has a market cap of $6.24 billion; its shares were traded at around $36.04 with and P/S ratio of 35.6. Vertex Pharmaceuticals Inc. had an annual average earning growth of 19.1% over the past 10 years.

For the quarter ended March 31, 2009, the Company's GAAP net loss was $161.5 million compared to a GAAP net loss for the quarter ended March 31, 2008 of $96.2 million.

VRTX is in the portfolio of Edward Owens of Vanguard Health Care Fund.

In May, Sell: CEO Joshua S Boger sold 22,050 shares of VRTX stock and the price of the stock has increased by 24.49% since. Sell: EVP & CFO Ian F Smith has been selling shares since February. Sell: Director Joshua S Boger sold 19,200 shares total this month; the price increased more than 6% since his latest sell. Sell: EVP Global R&D, CSO Peter Mueller and Sell: Director [url=http://www.gurufocus.com/InsiderBuy.php?insider=CORDES+EUGENE ]Eugene Corde s[/url ] also both sold shares this month.